PPI to Shop Health Discovery's Patents for Fields Outside of Healthcare | GenomeWeb
NEW YORK (GenomeWeb News) – Looking to monetize its patent portfolio, Health Discovery Corp. said today that Patent Profit International will market the firm’s patent portfolio to third parties for applications outside of biomarker discovery and other healthcare applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.